Elanco Animal Health Incorporated (ELAN) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "ELAN"
      ],
      "issuer_cik": "0001739104",
      "owner_cik": "0001797894",
      "accession_number": "0001797894-26-000006",
      "form_type": "4",
      "filing_date": "2026-10-19",
      "period_of_report": "2026-10-15",
      "issuer_name": "Elanco Animal Health Inc",
      "issuer_trading_symbol": "ELAN",
      "owner_name": "Bettington Timothy J",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "SEE REMARKS",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-15",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 4350,
      "transaction_price_per_share": 23,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 138911,
      "transaction_value": 100050,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2026."
        }
      ],
      "remarks": "Executive Vice President, Center of Strategic Growth\nExhibit List: Exhibit 24-Power of Attorney"
    },
    {
      "tickers": [
        "ELAN"
      ],
      "issuer_cik": "0001739104",
      "owner_cik": "0001352090",
      "accession_number": "0001352090-26-000006",
      "form_type": "4",
      "filing_date": "2026-08-21",
      "period_of_report": "2026-08-20",
      "issuer_name": "Elanco Animal Health Inc",
      "issuer_trading_symbol": "ELAN",
      "owner_name": "Kurzius Lawrence Erik",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-08-20",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 40000,
      "transaction_price_per_share": 23.398,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 188647,
      "transaction_value": 935920,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.